vs
Side-by-side financial comparison of BANCFIRST CORP (BANF) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $181.0M, roughly 1.1× BANCFIRST CORP). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 32.9%, a 24.5% gap on every dollar of revenue. BANCFIRST CORP produced more free cash flow last quarter ($237.0M vs $142.2M).
BancFirst Corporation is an Oklahoma-based financial services holding company. The company operates three subsidiary banks, BancFirst, an Oklahoma state-chartered bank; and Pegasus Bank and Worthington Bank, both Texas state-chartered banks.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
BANF vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $181.0M | $207.8M |
| Net Profit | $59.5M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 41.6% | 52.2% |
| Net Margin | 32.9% | 57.4% |
| Revenue YoY | 11.1% | — |
| Net Profit YoY | 5.3% | 330.1% |
| EPS (diluted) | $1.75 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $181.0M | — | ||
| Q3 25 | $175.5M | $207.8M | ||
| Q2 25 | $169.3M | — | ||
| Q1 25 | $164.8M | — | ||
| Q4 24 | $162.9M | — | ||
| Q3 24 | $163.7M | $0 | ||
| Q2 24 | $153.8M | $0 | ||
| Q1 24 | $151.0M | $0 |
| Q4 25 | $59.5M | — | ||
| Q3 25 | $62.7M | $119.2M | ||
| Q2 25 | $62.3M | — | ||
| Q1 25 | $56.1M | — | ||
| Q4 24 | $56.5M | — | ||
| Q3 24 | $58.9M | $-51.8M | ||
| Q2 24 | $50.6M | $-52.8M | ||
| Q1 24 | $50.3M | $-39.6M |
| Q4 25 | 41.6% | — | ||
| Q3 25 | 45.0% | 52.2% | ||
| Q2 25 | 47.1% | — | ||
| Q1 25 | 43.1% | — | ||
| Q4 24 | 44.2% | — | ||
| Q3 24 | 45.2% | — | ||
| Q2 24 | 42.4% | — | ||
| Q1 24 | 42.5% | — |
| Q4 25 | 32.9% | — | ||
| Q3 25 | 35.7% | 57.4% | ||
| Q2 25 | 36.8% | — | ||
| Q1 25 | 34.0% | — | ||
| Q4 24 | 34.7% | — | ||
| Q3 24 | 36.0% | — | ||
| Q2 24 | 32.9% | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | $1.75 | — | ||
| Q3 25 | $1.85 | $1.33 | ||
| Q2 25 | $1.85 | — | ||
| Q1 25 | $1.66 | — | ||
| Q4 24 | $1.68 | — | ||
| Q3 24 | $1.75 | $-0.60 | ||
| Q2 24 | $1.51 | $-0.68 | ||
| Q1 24 | $1.50 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.9B | $1.1B |
| Total Assets | $14.8B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $786.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | — | $701.7M | ||
| Q1 24 | — | $698.8M |
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.8B | $1.1B | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.5B | $931.7M | ||
| Q1 24 | $1.5B | $935.3M |
| Q4 25 | $14.8B | — | ||
| Q3 25 | $14.2B | $1.2B | ||
| Q2 25 | $14.0B | — | ||
| Q1 25 | $14.0B | — | ||
| Q4 24 | $13.6B | — | ||
| Q3 24 | $13.3B | $1.2B | ||
| Q2 24 | $12.7B | $973.7M | ||
| Q1 24 | $12.6B | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $285.3M | $142.2M |
| Free Cash FlowOCF − Capex | $237.0M | $142.2M |
| FCF MarginFCF / Revenue | 130.9% | 68.4% |
| Capex IntensityCapex / Revenue | 26.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.79× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $430.7M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $285.3M | — | ||
| Q3 25 | $75.4M | $142.2M | ||
| Q2 25 | $78.1M | — | ||
| Q1 25 | $77.0M | — | ||
| Q4 24 | $261.2M | — | ||
| Q3 24 | $77.6M | $-49.2M | ||
| Q2 24 | $100.2M | $-32.9M | ||
| Q1 24 | $66.3M | $-43.8M |
| Q4 25 | $237.0M | — | ||
| Q3 25 | $63.7M | $142.2M | ||
| Q2 25 | $64.4M | — | ||
| Q1 25 | $65.6M | — | ||
| Q4 24 | $224.5M | — | ||
| Q3 24 | $72.4M | $-49.7M | ||
| Q2 24 | $94.1M | $-33.9M | ||
| Q1 24 | $56.1M | $-45.1M |
| Q4 25 | 130.9% | — | ||
| Q3 25 | 36.3% | 68.4% | ||
| Q2 25 | 38.0% | — | ||
| Q1 25 | 39.8% | — | ||
| Q4 24 | 137.8% | — | ||
| Q3 24 | 44.2% | — | ||
| Q2 24 | 61.2% | — | ||
| Q1 24 | 37.1% | — |
| Q4 25 | 26.7% | — | ||
| Q3 25 | 6.7% | 0.0% | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 6.9% | — | ||
| Q4 24 | 22.5% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 6.8% | — |
| Q4 25 | 4.79× | — | ||
| Q3 25 | 1.20× | 1.19× | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 4.62× | — | ||
| Q3 24 | 1.32× | — | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 1.32× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
